Literature DB >> 6520483

New establishment and characterization of a carcinoembryonic antigen (CEA)-producing cell line from a human carcinoma of the uterine cervix.

M Kawabata.   

Abstract

A new human cell line (TC-S) was established from a metastatic lesion of a inguinal lymph node of a large-cell keratinizing squamous cell carcinoma of the uterine cervix. The population doubling time was 29.8 hours. Plating efficiency was 85.5%. The mitotic coefficient was 3.2%. The generation time was about 27 hours, (G1 phase 16 hours, S phase 4 hours, G2 phase 6 hours and M phase 1 hour). Electron microscopically, desmosomes, developed tonofilaments and macronucleoli were found. After subcutaneous transplantation into nude mice, the cells grew into solid tumors that killed the mice. Histopathologically, the tumors formed in nude mice showed keratinizing squamous cell carcinoma, which resembled those of the original cervical cancer and the metastatic lymph node. The TC-S cells produced carcinoembryonic antigen (CEA). By the scanning microdensitometric and flow cytometric analyses, the TC-S was classified as hyperploid with a hyperquadroploidy mode.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6520483

Source DB:  PubMed          Journal:  Nihon Sanka Fujinka Gakkai Zasshi        ISSN: 0300-9165


  2 in total

1.  Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).

Authors:  I Fukazawa; N Inaba; Y Ota; N Sato; S Shirotake; H Iwasawa; S Sekiya; H Takamizawa; N Suzuki; H Tokita
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

2.  Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.

Authors:  Takuya Asano; Yoshihiko Hirohashi; Toshihiko Torigoe; Tasuku Mariya; Ryota Horibe; Takafumi Kuroda; Yuta Tabuchi; Hiroshi Saijo; Kazuyo Yasuda; Masahito Mizuuchi; Akari Takahashi; Hiroko Asanuma; Tadashi Hasegawa; Tsuyoshi Saito; Noriyuki Sato
Journal:  Oncotarget       Date:  2016-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.